Background
Lactic acid bacteria (LAB) have been widely used in various fields because of their probiotic effects, and the exopolysaccharide (EPS) produced by LAB has attracted extensive attention due to its versatile bioactivities. However, the biosynthesis of EPS is a complicated process, and the low yield of EPS, especially heteropolysaccharide, remains a major bottleneck for industrial applications. In addition, the antibacterial activity of EPS from LAB endows it wide application prospect in food and medicine fields. Therefore, it was quite necessary to elucidate the biosynthetic pathways of EPS in LAB and explore methods to regulate EPS synthesis.
Scope and approach
This paper reviewed the biosynthesis of EPS from LAB and summarized the strategies of regulating EPS synthesis. Besides, the antibacterial characterization including the inhibitory activity and antibacterial mechanism of EPS as well as the methods to enhance its antibacterial activity was discussed.
Key findings and conclusions
LAB synthesize EPS through the Wzx/Wzy-dependent pathway, the synthase-dependent pathway and the extracellular synthesis pathway. Strategies including environmental stimulus, co-culture and metabolic engineering regulation could be performed to regulate the synthesis of EPS in LAB. What's more, the antibacterial activity of EPS could be enhanced via chemical modification, physical modification and preparation of composite materials. EPS exerted antibacterial activity by inhibition of biofilm formation and destruction of cell structure. Overall, this review may contribute to improving our understanding of the biosynthesis and function of EPS in LAB and further promoting the application of EPS in the food and medical industries.